<SEC-DOCUMENT>0001654954-18-000147-index.html : 20180105 <SEC-HEADER>0001654954-18-000147.hdr.sgml : 20180105 <ACCEPTANCE-DATETIME>20180105165717 ACCESSION NUMBER: 0001654954-18-000147 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20180105 DATE AS OF CHANGE: 20180105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-222445 FILM NUMBER: 18514030 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 </SEC-HEADER> <DOCUMENT> <TYPE>S-1 <SEQUENCE>1 <FILENAME>cvm_s1.htm <DESCRIPTION>FORM S-1 <TEXT> Document 1 - file: cvm_s1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5 <SEQUENCE>2 <FILENAME>cvm_ex5.htm <DESCRIPTION>LEGAL OPINION <TEXT> Document 2 - file: cvm_ex5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.XXX <SEQUENCE>3 <FILENAME>cvm_ex10x.htm <DESCRIPTION>AMENDMENT TO CONVERTIBLE PROMISSORY NOTES <TEXT> Document 3 - file: cvm_ex10x.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>4 <FILENAME>cvm_ex101.htm <DESCRIPTION>SECURITIES PURCHASE AGREEMENTS <TEXT> Document 4 - file: cvm_ex101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>5 <FILENAME>cvm_ex231.htm <DESCRIPTION>CONSENT OF HART AND HART, LLC <TEXT> Document 5 - file: cvm_ex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>6 <FILENAME>cvm_ex232.htm <DESCRIPTION>CONSENT OF BDO USA, LLP <TEXT> Document 6 - file: cvm_ex232.htm
</DOCUMENT> </SEC-DOCUMENT>